Submitted Successfully!
To reward your contribution, here is a gift for you: A free trial for our video production service.
Thank you for your contribution! You can also upload a video entry or images related to this topic.
Version Summary Created by Modification Content Size Created at Operation
1
Feiqing Ding
 -- 1423 2023-06-19 18:39:14 |
2 format correction
Dean Liu
 Meta information modification 1423 2023-06-20 04:59:11 |

Video Upload Options

Do you have a full video?
Send video materials Upload full video

Confirm

Are you sure to Delete?
Yes No
Cite
If you have any further questions, please contact Encyclopedia Editorial Office.
Zhong, X.; Wang, G.; Li, F.; Fang, S.; Zhou, S.; Ishiwata, A.; Tonevitsky, A.G.; Shkurnikov, M.; Cai, H.; Ding, F. Immunostimulatory Properties of β-Glucans. Encyclopedia. Available online: https://encyclopedia.pub/entry/45812 (accessed on 13 August 2024).
Zhong X, Wang G, Li F, Fang S, Zhou S, Ishiwata A, et al. Immunostimulatory Properties of β-Glucans. Encyclopedia. Available at: https://encyclopedia.pub/entry/45812. Accessed August 13, 2024.
Zhong, Xuemei, Guoqing Wang, Fu Li, Sixian Fang, Siai Zhou, Akihiro Ishiwata, Alexander G. Tonevitsky, Maxim Shkurnikov, Hui Cai, Feiqing Ding. "Immunostimulatory Properties of β-Glucans" Encyclopedia, https://encyclopedia.pub/entry/45812 (accessed August 13, 2024).
Zhong, X., Wang, G., Li, F., Fang, S., Zhou, S., Ishiwata, A., Tonevitsky, A.G., Shkurnikov, M., Cai, H., & Ding, F. (2023, June 19). Immunostimulatory Properties of β-Glucans. In Encyclopedia. https://encyclopedia.pub/entry/45812
Zhong, Xuemei, et al. "Immunostimulatory Properties of β-Glucans." Encyclopedia. Web. 19 June, 2023.
Immunostimulatory Properties of β-Glucans
Edit
This entry is adapted from the peer-reviewed paper 10.3390/pharmaceutics15061615

β-glucan, one of the homopolysaccharides composed of D-glucose, exists widely in cereals and microorganisms and possesses various biological activities, including anti-inflammatory, antioxidant, and anti-tumor properties. More recently, there has been mounting proof that β-glucan functions as a physiologically active “biological response modulator (BRM)”, promoting dendritic cell maturation, cytokine secretion, and regulating adaptive immune responses—all of which are directly connected with β-glucan-regulated glucan receptors.

β-glucans immune system dendritic cells adjuvants

1. Introduction

β-glucan is a kind of polysaccharide with multiple physiological functions and is known as a “biological response regulator” because of its multiple biological functions [1]. The first defensive line of body immunity is innate immunity. In its early stage, it mainly uses phagocytic cells such as macrophages and neutrophils to engulf and kill pathogens invading the body and then further activates the adaptive immune system by secreting cytokines and chemokines. β-glucan has been found to affect several types of immune cells, including macrophages, natural killer cells, and neutrophils, resulting in various immunological effects. In recent decades, tumor immunotherapy has made extensive use of β-glucan as a natural biological effect regulator [2]. Current clinical applications of β-glucans include yeast, lentinan, Coriolus versicolor polysaccharide, mycobacterium polysaccharide, and oat. The different types of β-glucan influence the strength and immune response, depending on the source, structure, water solubility, and molecular weight [3]. The body recognizes invading pathogenic microorganisms through the pattern recognition receptor (PRR) and initiates the body’s immune response to pathogens through a series of biochemical reactions. Currently, the following β-glucan receptors have been identified: dendritic cell (DC)-associated C-type lectin-1 (Dectin-1) [4], complement receptor 3 (CR3), cluster of differentiation 11b (CD11b)/CD18, αMβ2-integrin, macrophage differentiation antigen-1 (Mac-1) [5][6], lactosylceramide (LacCer) [7], and scavenger receptors (SRs) [8].

2. Immunostimulatory Properties of (1→3)-β-Glucan

As a natural barrier of the human body, the immune system has the functions of immune surveillance, defense, and regulation. It can be divided into adaptive immunity and innate immunity. The former is subdivided into cellular immunity and humoral immunity, which are respectively exerted by T lymphocytes and B lymphocytes, and the latter is mainly exerted by innate immune cells, such as monocyte macrophages and natural killer (NK) cells [9]. Therefore, modern medicine mainly evaluates immune function from four aspects: cellular immunity, humoral immunity, mononuclear macrophage phagocytosis, and NK cell activity. Carbohydrates are common surface molecules in biological systems. Due to their rich structural diversity, carbohydrate molecules play an important role in cell recognition and signal transduction, including immune recognition and activation [10][11]. Furthermore, (1→3)-β-glucan is a polysaccharide adjuvant widely existing in bacterial and fungal cell walls, which can stimulate antibacterial immune response [11]. In the 1950s, Dr. Pillemer first discovered and reported that there was a substance in the yeast cell wall that could improve immunity [12]. In later research, Diluzio’s group discovered that the immunity-boosting substance in the yeast cell wall was (1→3)-β-glucan, isolated from baker’s yeast [13][14].
Yeast (1→3)-β-glucan activates various immune cells, including macrophages and neutrophils, leading to increased production of interleukin (IL), cytokinin, and special antibodies. This comprehensive stimulation of the immune system prepares the body to better fight against diseases [15][16]. In addition, yeast (1→3)-β-glucan restores the ability of lymphocytes to produce cytokines such as IL-1 and effectively regulates immune function [17][18][19]. Many experiments have indicated that yeast (1→3)-β-glucan promotes the production of IgM antibodies, improving humoral immunity. Moreover, yeast (1→3)-β-glucan activates toll-like receptor 2 (TLR2), inducing nuclear factor (NF)- κB activation and tumor necrosis factor (TNF)-α secretion, as well as regulatory antigen-presenting cells and immune tolerance [20][21]. The yeast (1→3)-β-glucan-activated cells stimulate the host’s non-specific defense mechanism and are thus being studied for their potential in cancer, infectious disease, and wound treatment. In 2008, β-glucan extracted from S. cerevisiae’s yeast was released by the US Food and Drug Administration (FDA) as a safe food ingredient that can be added to general food. It is a very rare active immune substance, which can kill harmful viruses and maintain good immunity. Many years ago, National Aeronautics and Space Administration (NASA) listed yeast glucan as a food for astronauts to enhance their immunity.
Many researchers have not only demonstrated the regulatory effect of yeast (1→3)-β-glucan on immunity, such as induction of autoimmune arthritis or enhancement of nitric oxide (NO) synthesis, through in vitro cell experiments or in vivo experiments in mice, respectively [22][23][24], but also showed that β-glucan also has the effect of immune stimulation on zebrafish [25][26].
Wu et al. reported that the addition of (1→3)-β-glucan can also lessen the inflammatory response after lipopolysaccharide (LPS) stress [27]. Yeast (1→3)-β-glucan is also an important enhancer of mucosal immunity in the digestive tract [28]. The digestive system is the primary point of contact for many pathogens and foreign substances, and mucosal immunity in the system plays a vital role in defending against these threats. Additionally, it has also been found that (1→3)-β-glucan can improve the level of lysozyme in animal serum and the antibody titer [29]. Yeast (1→3)-β-glucan can activate neutrophils and phagocytes in gastrointestinal tissues, thereby further activating and affecting the “immune nerve endocrine” regulatory network, enhancing its anti-infection, anti-stress, and cellular adaptive protection capabilities and also enhancing macrophage-mediated tissue repair, accelerating the repair process of ulcers, and improving the repair quality [30]. Yeast β-glucan has the ability to bind with surface receptors of macrophages, neutrophils, and lymphocytes, which can affect the cellular signaling process, activate the immune activity of lymphocytes, and enable them to swiftly reach the site of infection [31]. It acts as an immune response booster and facilitates whey protein. Whey protein is a high-quality protein that contains all of the essential amino acids needed by the body. Combining with β-glucan, it can activate immune cells. While whey protein provides the building blocks necessary for these cells to function properly, they can work synergistically to enhance the immune response [32]. The latest research found that pre-treatment of mice with (1→3)-β-glucan can reduce the growth of tumors and elucidated that β-glucan transcriptomically and epigenetically rewires granulopoiesis and reprograms neutrophils towards an anti-tumor phenotype to form a long-term innate immune memory, i.e., trained immunity. Moreover, the anti-tumor effects of (1→3)-β-glucan-induced trained immunity can be transferred to recipient initial mice via bone marrow transplantation [33]. Furthermore, (1→3)-β-glucan can stimulate the innate immunity of Pagrus auratus by enhancing the respiratory burst of macrophages [34]. Besides for humans, Chang et al. also showed that the addition of (1→3)-β-glucan to the diet of shrimp enhanced the bacteriophage activity of blood cells, cell adhesion, and production of reactive oxygen species [35].
Macrophages are essential to every stage of host defense and are engaged in both innate and adaptive immune responses in case of infection. The pathogen crosses the epithelial barrier, following phagocytosis by macrophages and digestion by lysosomal enzymes, which are important processes for presenting antigens from the pathogens as phagocytic activity, and lysosomal enzymes determine the function of macrophages [36]. The secretion of cytokines (IL-1, IL-6, IL-8, IL-12, TNF-a) and inflammatory mediators (NO, hydrogen peroxide (H2O2)) are also the downstream effect of these cells. Thus, β-glucan-activated macrophage function enhances host immune defense (Figure 1) [37][38]. Furthermore, (1→3)-β-Glucan is an effective immunomodulator [39][40][41], which can enhance the anti-tumor activity of peritoneal macrophages. In vitro studies showed that the killing effect of monocytes and neutrophils on microorganisms in healthy volunteers was enhanced after taking (1→3)-β-glucan. In addition to activating macrophages, T cells, and natural killer (NK) cells, (1→3)-β-glucan also activates complement components through a selective activation pathway. When (1→3)-β-glucan is present, it can bind to complement component C3, which triggers a cascade of reactions leading to the activation of the alternative pathway. This results in the formation of the C3 convertase enzyme, which cleaves C3 into iC3b. iC3b then binds to the surface of the pathogen, marking it for destruction by immune cells [5][6]. Activation of complement components through this pathway is important because it allows for a more targeted response to pathogens, without causing excessive inflammation or tissue damage. Vaccine adjuvants have a variety of mechanisms, typically including storage effects, promoting antigen presentation, increasing the secretion of immunomodulatory cytokines to control cellular responses with T and B, stimulating innate immunity, and indirectly modulating adaptive immune responses [42]. At present, (1→3)-β-glucan is an attractive candidate for immune adjuvants and is used in a wide range of vaccine development. It can activate the immune system and induce the Th1 immune response [43][44]. The potential effects of (1→3)-β-glucan as an adjuvant on the effectiveness of a severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus vaccination were discussed by Alfredo’s group (Figure 1) [45].
Pharmaceutics 15 01615 g003 550
Figure 1. Immunomodulatory action of (1→3)-β-glucans.

References

  1. Demleitner, S.; Kraus, J.; Franz, G. Synthesis and antitumour activity of derivatives of curdlan and lichenan branched at C-6. Carbohydr. Res. 1992, 226, 239–246.
  2. Yan, J.; Větvička, V.C.; Xia, Y.; Coxon, A.; Carroll, M.C.; Mayadas, T.N.; Ross, G.D. β-Glucan, a “specific” biologic response modifier that uses antibodies to target tumors for cytotoxic recognition by leukocyte complement receptor type 3 (CD11b/CD18). J. Immunol. 1999, 163, 3045–3052.
  3. Synytsya, A.; Novák, M. Structural diversity of fungal glucans. Carbohydr. Polym. 2013, 92, 792–809.
  4. Batbayar, S.; Lee, D.-H.; Kim, H.-W. Immunomodulation of fungal β-glucan in host defense signaling by dectin-1. Biomol. Ther. 2012, 20, 433–445.
  5. Legentil, L.; Paris, F.; Ballet, C.; Trouvelot, S.; Daire, X.; Vetvicka, V.; Ferrières, V. Molecular interactions of β-(1→3)-glucans with their receptors. Molecules 2015, 20, 9745–9766.
  6. Akramiene, D.; Kondrotas, A.; Didziapetriene, J.; Kevelaitis, E. Effects of beta-glucans on the immune system. Medicina 2007, 43, 597–606.
  7. Iwabuchi, K.; Masuda, H.; Kaga, N.; Nakayama, H.; Matsumoto, R.; Iwahara, C.; Yoshizaki, F.; Tamaki, Y.; Kobayashi, T.; Hayakawa, T. Properties and functions of lactosylceramide from mouse neutrophils. Glycobiology 2015, 25, 655–668.
  8. PrabhuDas, M.; Bowdish, D.; Drickamer, K.; Febbraio, M.; Herz, J.; Kobzik, L.; Krieger, M.; Loike, J.; Means, T.K.; Moestrup, S.K. Standardizing scavenger receptor nomenclature. J. Immunol. 2014, 192, 1997–2006.
  9. Pillemer, L.; Blum, L.; Lepow, I.H.; Ross, O.A.; Todd, E.W.; Wardlaw, A.C. The properdin system and immunity: I. Demonstration and isolation of a new serum protein, properdin, and its role in immune phenomena. Science 1954, 120, 279–285.
  10. Mahla, R.S.; Reddy, M.C.; Prasad, D.V.R.; Kumar, H. Sweeten PAMPs: Role of sugar complexed PAMPs in innate immunity and vaccine biology. Front. Immunol. 2013, 4, 248.
  11. Varki, A. Biological roles of glycans. Glycobiology 2017, 27, 3–49.
  12. Vetvicka, V. Glucan-immunostimulant, adjuvant, potential drug. World J. Clin. Oncol. 2011, 2, 115.
  13. Di Luzio, N.; McNamee, R.; Williams, D.; Gilbert, K.; Spanjers, M. Glucan induced inhibition of tumor growth and enhancement of survival in a variety of transplantable and spontaneous murine tumor models. In Macrophages and Lymphocytes; Springer: Berlin/Heidelberg, Germany, 1980; pp. 269–290.
  14. Di Luzio, N.R. Immunopharmacology of glucan: A broad spectrum enhancer of host defense mechanisms. Trends Pharmacol. Sci. 1983, 4, 344–347.
  15. Demir, G.; Klein, H.; Mandel-Molinas, N.; Tuzuner, N. Beta glucan induces proliferation and activation of monocytes in peripheral blood of patients with advanced breast cancer. Int. Immunopharmacol. 2007, 7, 113–116.
  16. Williams, D.L.; Mueller, A.; Browder, W. Glucan-based macrophage stimulators. Clin. Immunother. 1996, 5, 392–399.
  17. Salama, S.F. Beta-glucan ameliorates gamma-rays induced oxidative injury in male swiss albino rats. Pak. J. Zool. 2011, 43, 933–939.
  18. Iraz, M.; Iraz, M.; Eşrefoğlu, M.; Aydin, M.Ş. Protective effect of\beta-glucan on acute lung injury induced bylipopolysaccharide in rats. Turk. J. Med. Sci. 2015, 45, 261–267.
  19. Barton, C.; Vigor, K.; Scott, R.; Jones, P.; Lentfer, H.; Bax, H.J.; Josephs, D.H.; Karagiannis, S.N.; Spicer, J.F. Beta-glucan contamination of pharmaceutical products: How much should we accept? Cancer Immunol. Immun. 2016, 65, 1289–1301.
  20. Sato, M.; Sano, H.; Iwaki, D.; Kudo, K.; Konishi, M.; Takahashi, H.; Takahashi, T.; Imaizumi, H.; Asai, Y.; Kuroki, Y. Direct binding of Toll-like receptor 2 to zymosan, and zymosan-induced NF-κB activation and TNF-α secretion are down-regulated by lung collectin surfactant protein A. J. Immunol. 2003, 171, 417–425.
  21. Dillon, S.; Agrawal, S.; Banerjee, K.; Letterio, J.; Denning, T.L.; Oswald-Richter, K.; Kasprowicz, D.J.; Kellar, K.; Pare, J.; van Dyke, T. Yeast zymosan, a stimulus for TLR2 and dectin-1, induces regulatory antigen-presenting cells and immunological tolerance. J. Clin. Investig. 2006, 116, 916–928.
  22. Yoshitomi, H.; Sakaguchi, N.; Kobayashi, K.; Brown, G.D.; Tagami, T.; Sakihama, T.; Hirota, K.; Tanaka, S.; Nomura, T.; Miki, I. A role for fungal β-glucans and their receptor Dectin-1 in the induction of autoimmune arthritis in genetically susceptible mice. J. Exp. Med. 2005, 201, 949–960.
  23. Ohno, N.; Egawa, Y.; Hashimoto, T.; Adachi, Y.; Yadomae, T. Effect of β-glucans on the nitric oxide synthesis by peritoneal macrophage in mice. Biol. Pharm. Bull. 1996, 19, 608–612.
  24. Hashimoto, T.; Ohno, N.; Adachi, Y.; Yadomae, T. Enhanced production of inducible nitric oxide synthase by β-glucans in mice. FEMS Immunol. Med. Microbiol. 1997, 19, 131–135.
  25. Medina-Gali, R.M.; del Mar Ortega-Villaizan, M.; Mercado, L.; Novoa, B.; Coll, J.; Perez, L. Beta-glucan enhances the response to SVCV infection in zebrafish. Dev. Comp. Immunol. 2018, 84, 307–314.
  26. Petit, J.; Wiegertjes, G.F. Long-lived effects of administering β-glucans: Indications for trained immunity in fish. Dev. Comp. Immunol. 2016, 64, 93–102.
  27. Wu, C.; Xu, Q.; Wang, R.; Qin, L.; Peng, X.; Hu, L.; Liu, Y.; Fang, Z.; Lin, Y.; Xu, S.; et al. Effects of dietary β-glucan supplementation on growth performance and immunological and metabolic parameters of weaned pigs administered with Escherichia coli lipopolysaccharide. Food Funct. 2018, 9, 3338–3343.
  28. Effects of Bread Yeast Cell Wall Beta-Glucans on Mice with Loperamide-Induced Constipation. J. Med. Food 2019, 22, 1009–1021.
  29. Cao, Y.; Sun, Y.; Zou, S.; Duan, B.; Sun, M.; Xu, X. Yeast β-Glucan Suppresses the Chronic Inflammation and Improves the Microenvironment in Adipose Tissues of ob/ob Mice. J. Agric. Food Chem. 2018, 66, 621–629.
  30. Han, F.; Fan, H.; Yao, M.; Yang, S.; Han, J. Oral administration of yeast β-glucan ameliorates inflammation and intestinal barrier in dextran sodium sulfate-induced acute colitis. J. Funct. Foods 2017, 35, 115–126.
  31. Pelizon, A.C.; Kaneno, R.; Soares, A.; Meira, D.A.; Sartori, A. Immunomodulatory activities associated with β-glucan derived from Saccharomyces cerevisiae. Physiol. Res. 2005, 54, 557–564.
  32. Hellinga, A.H.; Tsallis, T.; Eshuis, T.; Triantis, V.; Ulfman, L.H.; van Neerven, R.J.J. In Vitro Induction of Trained Innate Immunity by bIgG and Whey Protein Extracts. Int. J. Mol. Sci. 2020, 21, 9077.
  33. Kalafati, L.; Kourtzelis, I.; Schulte-Schrepping, J.; Li, X.; Hatzioannou, A.; Grinenko, T.; Hagag, E.; Sinha, A.; Has, C.; Dietz, S.; et al. Innate Immune Training of Granulopoiesis Promotes Anti-tumor Activity. Cell 2020, 183, 771–785.e12.
  34. Cook, M.T.; Hayball, P.J.; Hutchinson, W.; Nowak, B.; Hayball, J.D. The efficacy of a commercial β-glucan preparation, EcoActiva™, on stimulating respiratory burst activity of head-kidney macrophages from pink snapper (Pagrus auratus), Sparidae. Fish Shellfish Immunol. 2001, 11, 661–672.
  35. Muthusamy, G.; Joardar, S.N.; Samanta, I.; Isore, D.P.; Roy, B.; Maiti, K. β-glucan from edible mushroom (Pleurotus florida) enhances mucosal immunity in poultry. Adv. Anim. Vet. Sci. 2013, 1, 116–119.
  36. Kwon, K.H.; Kim, K.I.; Jun, W.J.; Shin, D.H.; Cho, H.Y.; Hong, B.S. In Vitro and in Vivo Effects of Macrophage-Stimulatory Polysaccharide from Leaves of Perilla frutescens var crispa. Biol. Pharm. Bull. 2002, 25, 367–371.
  37. Suzuki, I.; Tanaka, H.; Kinoshita, A.; Oikawa, S.; Osawa, M.; Yadomae, T. Effect of orally administered β-glucan on macrophage function in mice. Int. J. Immunopharmacol. 1990, 12, 675–684.
  38. Goodridge, H.S.; Wolf, A.J.; Underhill, D.M. β-glucan recognition by the innate immune system. Immunol. Rev. 2009, 230, 38–50.
  39. Chan, G.C.; Chan, W.K.; Sze, D.M. The effects of β-glucan on human immune and cancer cells. J. Hematol. Oncol. 2009, 2, 25.
  40. Ross, P.; Farrell, M.P. The Road to Structurally Defined β-Glucans. Chem. Rec. 2021, 21, 3178–3193.
  41. De Marco Castro, E.; Calder, P.C.; Roche, H.M. β-1,3/1,6-Glucans and Immunity: State of the Art and Future Directions. Mol. Nutr. Food Res. 2021, 65, e1901071.
  42. Chauhan, N.; Tiwari, S.; Iype, T.; Jain, U. An overview of adjuvants utilized in prophylactic vaccine formulation as immunomodulators. Expert Rev. Vaccines 2017, 16, 491–502.
  43. Petrovsky, N.; Cooper, P.D. Carbohydrate-based immune adjuvants. Expert Rev. Vaccines 2011, 10, 523–537.
  44. Hu, X.; Liu, R.; Zhu, N. Enhancement of humoral and cellular immune responses by monophosphoryl lipid A (MPLA) as an adjuvant to the rabies vaccine in BALB/c mice. Immunobiology 2013, 218, 1524–1528.
  45. Córdova-Martínez, A.; Caballero-García, A.; Roche, E.; Noriega, D.C. β-Glucans Could Be Adjuvants for SARS-CoV-2 Virus Vaccines (COVID-19). Int. J. Environ. Res. Public Health 2021, 18, 12636.
More
© Text is available under the terms and conditions of the Creative Commons Attribution (CC BY) license; additional terms may apply. By using this site, you agree to the Terms and Conditions and Privacy Policy.
Upload a video for this entry
Information
Subjects: Others
Contributors MDPI registered users' name will be linked to their SciProfiles pages. To register with us, please refer to https://encyclopedia.pub/register :
Xuemei Zhong
,
Guoqing Wang
,
Fu Li
,
Sixian Fang
,
Siai Zhou
,
Akihiro Ishiwata
,
Alexander G. Tonevitsky
,
Maxim Shkurnikov
,
Hui Cai
,
Feiqing Ding
View Times: 279
Revisions: 2 times (View History)
Update Date: 20 Jun 2023
Table of Contents
    1000/1000
    Hot Most Recent
    Video Production Service
    Feedback